Skip to main content
Log in

Indikationen zur Therapie von Stenosen der A. carotis

Indications for treating stenoses of the carotid artery

  • Leitthema
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Das jährliche Schlaganfallrisiko bei asymptomatischer Karotisstenose beträgt ca. 1% bei Patienten mit weniger als 70%igen Stenosen (NASCET-Methodik) und 2–5% bei über 70%igen Stenosen der A. carotis interna. Das Rezidivrisiko symptomatischer Stenosen ist mit ca. 15% im 1. Jahr beträchtlich höher. Seit über 10 Jahren ist die Effektivität der Karotisthrombendarteriektomie (CEA) in der Sekundärprävention symptomatischer Karotisstenosen bewiesen, auch nimmt die Evidenz zu, dass sie bei asymptomatischen Stenosen von Nutzen ist. Von besonderer Effektivität ist die CEA bei hochgradigen Stenosen, Männern, älteren Patienten und bei bilateralen Prozessen. Eine differenzierte Haltung ist gegenüber der interventionellen, endovaskulären Therapie notwendig. Vielerorts wird diese Therapie aufgrund einer im Vergleich zur CEA scheinbar geringeren Invasivität zu unkritisch indiziert und durchgeführt. Es gibt sicher bereits zahlreiche Erfahrungen mit dieser Therapie, aber nach den Grundsätzen der evidenzbasierten Medizin ist die Effektivität der stentgeschützen Angioplastie bisher nicht unter Beweis gestellt worden. Insbesondere bei Patienten mit symptomatischer Karotisstenose sollte dieses Verfahren überwiegend im Rahmen randomisierter Studien (z. B. SPACE) angewandt werden.

Abstract

The annual stroke risk for patients with asymptomatic stenoses of the carotid artery is around 1% in case of <70% stenosis (NASCET criteria) and 2–5% in patients with >70% stenosis. The risk of recurrent ischemic events for patients with symptomatic stenoses is much higher, around 15% during the first year. For more than 10 years, the efficacy of carotid surgery has been proven, and there is growing evidence to support surgery in case of asymptomatic stenosis. Patients with severe stenoses, male or elderly patients, and those with bilateral stenoses benefit more from surgery. Carotid artery stenting has not proven its safety or efficacy. Despite this lack of evidence, the method is used in many centers as an alternative to surgery. Especially symptomatic carotid artery stenosis should be used mainly in the setting of a randomized trial such as SPACE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Adams HP, Brott TG, Crowell RM et al. (1994) Guidelines for the managment of patients with acute ischemic stroke. Stroke 25:1901–1914

    PubMed  Google Scholar 

  2. Biller J, Feinberg WM, Castaldo JE et al. (1998) Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 29:554–562

    CAS  PubMed  Google Scholar 

  3. Cavatas Group (2001) Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357:1729–1737

    PubMed  Google Scholar 

  4. Davidson M, McKenney J, Stein E et al. (1997) Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I. Am J Cardiol 79:1475–1481

    Article  CAS  PubMed  Google Scholar 

  5. Eckert B, Zeumer H (2003) Editorial comment—Carotid artery stenting with or without protection devices? Strong opinions, poor evidence! Stroke 34:1941–1943

  6. Hobson RW 2nd (2001) Carotid angioplasty-stent: clinical experience and role for clinical trials. J Vasc Surg 33 [Suppl 2]:117–123

    Google Scholar 

  7. Mas JL, Chatellier G, Beyssen B (2004) Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke 35:18–20

    Google Scholar 

  8. Mayberg M, Wilson E, Yatsu F et al. (1991) Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA 226:3289–3294

    Google Scholar 

  9. MRC/BHF publication committee (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22

    Article  PubMed  Google Scholar 

  10. Ringleb P, Kunze A, Allenberg JR et al. (2003) Evaluation der stentgeschützten Angioplastie zur Therapie von symptomatischen Stenosen der A. carotis: SPACE und andere randomisierte Studien. Nervenarzt 74:482–488

    CAS  PubMed  Google Scholar 

  11. Rothwell P, Gutnikov S, Mayberg M et al. (2001) A pooled analysis of individual patient data from trials of endarterectomy for symptomatic carotid stenosis: efficacy of surgery in important subgroups. Stroke 32:328

    Google Scholar 

  12. Rothwell PM (2004) Effective stroke prevention in patients with symptomatic carotid stenosis. Cerebrovasc Dis 17 [Suppl 1]:89–104

    Google Scholar 

  13. Rothwell PM, Gibson R, Warlow CP (2000) Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. On behalf of the European Carotid Surgery Trialists‘ Collaborative Group. Stroke 31:615–621

    CAS  PubMed  Google Scholar 

  14. The European Stroke Initiative Executive Committee and the EUSI Writing Committee (2003) European Stroke Initiative Recommendations for Stroke Management—Update 2003. Cerebrovasc Dis 16:311–337

    Article  Google Scholar 

  15. The North American Symptomatic Carotid Endarterectomy Trial Collaborators (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325:445–453

    PubMed  Google Scholar 

  16. Toole JF, and the Executive Committee for the Asymptomatic Carotid Atherosklerosis Study (1995) Endarterectomie for asymptomatic carotid artery stenosis. JAMA 273:1421–1428

    PubMed  Google Scholar 

  17. Warlow C (1991) MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialists‘ Collaborative Group. Lancet 337:1235–1243

    PubMed  Google Scholar 

  18. Wholey MH, Jarmolowski CR, Wholey M, Eles GR (2003) Carotid artery stent placement-ready for prime time? J Vasc Interv Radiol 14:1–10

    PubMed  Google Scholar 

  19. Yadav JS, for the SAPPHIRE Investigators (2002) Stenting and angioplasty with protection in patients at high risk for endarterectomy: The SAPPHIRE Study. Circulation 106:2

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ringleb, P., Kunze, A. & Hacke, W. Indikationen zur Therapie von Stenosen der A. carotis. Chirurg 75, 653–657 (2004). https://doi.org/10.1007/s00104-004-0882-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-004-0882-0

Schlüsselwörter

Keywords

Navigation